MATTHEW B KLEIN plan to sell securities of ClearPoint Neuro, Inc. under Form 144
2026-05-21SEC Filing 144 (0001950047-26-004887)
MATTHEW B KLEIN filed Form 144 to notify SEC of plan to sell 16000 units of ClearPoint Neuro, Inc. securities around 2026-05-21, with aggregate market value of $185,392.00. The total outstanding units is 29990000.0. The amount planned to be sold represents 0.05% of total outstanding units;